GlassScriptPhysician profile
Scott H Liang
NPI 1639124514
$9,137.34
in general payments reported to CMS, 2019-2025
38 companies · $1,252 in 2025
The $1,252 reported for 2025 was more than what 88% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $754 · 2020: $1,204 · 2021: $1,787 · 2022: $1,530 · 2023: $1,510 · 2024: $1,101 · 2025: $1,252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,856 · Education: $6.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,855.97 |
| Education | $6.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,868.22 | 2019-2025 | Ozempic, Rybelsus |
| Amgen INC. | $924.31 | 2019-2025 | Krystexxa, Repatha, Otezla |
| Astrazeneca Pharmaceuticals LP | $792.06 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $751.19 | 2019-2025 | Jardiance |
| Abbvie INC. | $722.26 | 2021-2025 | |
| Glaxosmithkline, LLC. | $484.39 | 2019-2025 | Trelegy Ellipta |
| Lilly USA, LLC | $403.11 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Medtronic, INC. | $313.84 | 2021-2023 | Micra |
| Pfizer INC. | $289.70 | 2020-2025 | |
| Medtronic Vascular, INC. | $244.54 | 2019-2020 | |
| Allergan, INC. | $237.87 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $234.66 | 2019-2024 | Xarelto |
| Kowa Pharmaceuticals America, INC. | $187.75 | 2019-2023 | Livalo, Seglentis |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $164.39 | 2022-2025 | Xifaxan, Trulance |
| Abbott Laboratories | $135.12 | 2019 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Liang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.